Advertisement

Advertisement

HotelsFoodShoppingCoffeeGroceryGas

Biocon Biologics Inc

Website

Advertisement

Advertisement

245 Main St Ste 2
Cambridge, MA 02142
https://www.biocon.com

Biocon Biologics Inc is a global biopharmaceutical company that specializes in the development and manufacturing of biosimilars, novel biologics, and branded formulations. With a wide global footprint and a strong focus on quality compliance, Biocon Biologics is committed to providing innovative healthcare solutions in key therapeutic areas.

Driven by a dedicated team of experts and supported by a robust research and development program, Biocon Biologics aims to make a positive impact on patients' lives through its portfolio of high-quality and affordable biopharmaceutical products.

Generated from the website

Also at this address

Root Capitol

Nanobiotix Corp

React Neuro

Medicem Inc

Own this business?
Claim it
See a problem?

You might also like

Blood derivatives

Tevard Biosciences Inc

Tevard Biosciences Inc, based in Newton Center, MA, is a pioneering biotechnology company focused on developing tRNA-based therapies to treat a wide range of genetic diseases. Founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with parents of children with Dravet syndrome, Tevard aims to revolutionize gene therapy approaches to cure genetic diseases such as Dravet syndrome and others caused by haploinsufficiency and nonsense mutations. With their unique tRNA-based platforms, Tevard is dedicated to providing durable cures for rare diseases by modulating mRNA function and restoring the expression of genes to normal levels appropriate for each type of cell. With a team of scientific, clinical, and industry leaders, Tevard is committed to bringing their innovative tRNA therapies to patients in a timely manner. Their lead focus is on Dravet syndrome, where they are pursuing a dual approach using Enhancer tRNAs Stabilization and Suppressor tRNAs to increase expression of the healthy copy of SCN1A and allow production of full-length protein off the faulty copy of the gene. Additionally, Tevard is actively developing cures for other genetic epilepsies, CNS indications, and non-CNS indications caused by haploinsufficiency and nonsense mutations, with the aim of addressing the needs of millions of patients worldwide.Generated from the website
Blood derivatives

Biogen Inc

Biogen, headquartered in Cambridge, MA, is a global biotechnology company at the forefront of pioneering innovative solutions for a variety of diseases, including Alzheimer's Disease, Multiple Sclerosis, and Spinal Muscular Atrophy. With a strong commitment to science and innovation, Biogen focuses on developing transformative medicines through research, clinical trials, and early access programs, while also prioritizing corporate responsibility by promoting health equity, diversity, and environmental sustainability.
Drugs acting on the respiratory system, Blood derivatives, Surgical instruments and apparatus

Biogen US Corp

Headquartered in Cambridge, Mass., Biogen Idec specializes in the field of biotechnology. Its core capabilities include drug discovery, research and development. The company s focus is the development of products related to oncology, neurology and immunology. Among the company s products are treatments for B-cell, non-Hodgkin s lymphomas; a treatment for relapsing forms of multiple sclerosis; and a treatment for psoriasis and psoriatic arthritis. In addition, the company has several licensed and dedicated bulk-manufacturing facilities engaged in protein manufacturing. James C. Mullen has been the chief executive officer of Biogen Indec for more than two years. He has been with the drug and biotechnology company for over 17 years. Mullen earned a BS degree from Rensselaer Polytech, and a MBA from Villanova. The company maintains research centers in Cambridge, Mass., and San Diego. Biogen Idec has additional offices in Canada, Australia, Japan and Europe, including international headquarters in Zug, Switzerland. The company currently employs approximately 3,400 people worldwide.
United States›Massachusetts›Cambridge›Biocon Biologics Inc

Partial Data by Infogroup (c) 2024. All rights reserved.

Advertisement

Advertisement

  • Get directions
  • MapQuest Travel
  • Route Planner
  • Print your map
  • Get help
  • Search the web
  • Send feedback
Learn more about our mobile apps.
  • Android app Google Play
  • Download on the App Store
  • Download on the Amazon Appstore
  • Enterprise solutions
  • Claim your business
  • Developer resources
  • Jobs
  • Advertise with us
  • Terms of use
  • Privacy policy
  • Data and licenses
  • About our ads
  • Do not sell